Precision nicotine metabolism-informed care for smoking cessation in Crohn’s disease: A pilot study

INTRODUCTION: Smoking is a strong risk factor for disease severity in Crohn’s disease (CD) and cessation improves outcomes. The nicotine metabolite ratio (NMR) predicts cessation success with pharmacotherapy: varenicline doubles cessation over nicotine replacement therapy (NRT) for “normal”, but not...

Descripción completa

Detalles Bibliográficos
Autores principales: Scoville, Elizabeth A., Tindle, Hilary A., Wells, Quinn S., Peyton, Shannon C., Gurwara, Shelly, Pointer, Stephanie O., Horst, Sara N., Schwartz, David A., Adams, Dawn W., Freiberg, Matthew S., Gatskie, Vanessa, King, Stephen, Abney, Lesa R., Beaulieu, Dawn B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098646/
https://www.ncbi.nlm.nih.gov/pubmed/32214373
http://dx.doi.org/10.1371/journal.pone.0230656

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098646/
https://www.ncbi.nlm.nih.gov/pubmed/32214373
http://dx.doi.org/10.1371/journal.pone.0230656

Ejemplares similares